2,332
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy children (6 months to 17 years of age): a randomized, multicenter, phase III clinical trial

, , ORCID Icon, , ORCID Icon &
Pages 681-689 | Received 03 Apr 2020, Accepted 08 Jul 2020, Published online: 26 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (2)